Experimental Hematology
Volume 35, Issue 5 , Pages 735-747 , May 2007

Interleukin-3 and erythropoietin cooperate in the regulation of the expression of erythroid-specific transcription factors during erythroid differentiation

  • Barbara Ghinassi

      Affiliations

    • Departments of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome
    • Biomorphology, University of Chieti-Pescara, Italy
    • ,
  • Maria Verrucci

      Affiliations

    • Departments of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome
    • ,
  • Katija Jelicic

      Affiliations

    • Departments of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome
    • ,
  • Antonella Di Noia

      Affiliations

    • Cell Biology and Neurosciences, Istituto Superiore Sanità, Rome
    • ,
  • Giovanni Migliaccio

      Affiliations

    • Cell Biology and Neurosciences, Istituto Superiore Sanità, Rome
    • ,
  • Anna Rita Migliaccio

      Affiliations

    • Departments of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanità, Rome
    • Pathology, University of Illinois, Chicago, Ill., USA
    • Corresponding Author InformationOffprint requests to: Anna Rita Migliaccio, Ph.D., Departments of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy

Received 27 November 2006 ,Revised 8 February 2007 ,Accepted 12 February 2007.

References 

  1. Papayannopoulou T, D'Andrea AD, Abkowitz JL, Migliaccio AR. Biology of erythropoiesis, erythroid differentiation, and maturation. In:  Hoffman R,  Benz E,  Sanford J, et al. editor. Hematology. Philadelphia: Elsevier Press; 2005;p. 267–288
  2. Metcalf D. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood. 1998;92:345–347
  3. Enver T, Heyworth CM, Dexter TM. Do stem cells play dice?. Blood. 1998;92:348–351
  4. Stewart A. Genetic Nomenclature Guide. Trends in Genetics. Cambridge, UK: Elsevier Science Publishers; 1995;
  5. Longmore G, Watowich S, Hilton D, Lodish H. The erythropoietin receptor: its role in hematopoiesis and myeloproliferative disease. J Cell Biol. 1993;123:1305–1308
  6. Orkin SH. Transcription factors that regulate lineage decisions. In:  Stamatoyannopoulous G,  Majerus PW,  Perlmutter R,  Varmus H editor. The Molecular Basis of Blood Disease. Philadelphia: WB Saunders; 2000;p. 80–102
  7. Chiba T, Ikawa Y, Todokoro K. GATA-1 transactivates the erythropoietin receptor gene and erythropoietin receptor-mediated signalling enhance GATA-1 expression. Nucleic Acids Res. 1991;19:3843–3848
  8. Zon LI, Youssoufian H, Mather C, Lodish HF, Orkin SH. Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci U S A. 1991;88:10638–10641
  9. Martin D, Zon LI, Mutter G, Orkin SH. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature. 1990;344:444–447
  10. Romeo PH, Prandini MH, Joulin V, et al. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature. 1990;344:447–449
  11. Yu C, Cantor AB, Yang H, et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med. 2002;195:1387–1395
  12. Migliaccio AR, Rana RA, Sanchez M, et al. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1 low mouse mutant. J Exp Med. 2003;197:281–296
  13. McDevitt MA, Shivdasani RA, Fujiwara Y, Yang H, Orkin SH. A “knockdown” mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A. 1997;94:6781–6785
  14. Takahashi S, Onodera K, Motohashi H, et al. Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 mice. J Biol Chem. 1997;272:12611–12615
  15. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 2002;21:3368–3376
  16. Bieker JJ. Kruppel-like factors: three fingers in many pies. J Biol Chem. 2001;14:34355–34358
  17. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 1990;61:49–59
  18. Shoji W, Yamamoto T, Obinata M. The helix-loop-helix protein Id inhibits differentiation of murine erythroleukemia cells. J Biol Chem. 1994;269:5078–5084
  19. Lister J, Forrester WC, Baron MH. Inhibition of an erythroid differentiation switch by the helix-loop-helix protein Id1. J Biol Chem. 1995;270:17939–17946
  20. Carroll M, Zhu Y, D'Andrea AD. Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle. Proc Natl Acad Sci U S A. 1995;92:2869–2873
  21. Yamaguchi Y, Zon LI, Ackerman SJ, Yamamoto M, Suda T. Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation. Blood. 1998;15:450–457
  22. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ. Demonstration of permanent factor-dependent multipotential erythroid/neutrophil/ basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci U S A. 1983;80:2931–2935
  23. Migliaccio G, Migliaccio AR, Kreider BL, Rovera G, Adamson JW. Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol. 1989;109:833–841
  24. Migliaccio G, Migliaccio AR, Adamson JW. The biology of hematopoietic growth factors: studies in vitro under serum-deprived conditions. Exp Hematol. 1990;9:1049–1055
  25. Amabile G, Di Noia A, Alfani E, et al. Isolation of TPO-dependent subclones from the multipotent 32D cell line. Blood Cell Mol Dis. 2005;35:241–252
  26. Migliaccio AR, Migliaccio G, D'Andrea A, et al. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc Natl Acad Sci U S A. 1991;15:11086–11090
  27. Chomcynski P, Sacchi N. Single-step method of RNA isolated by acid guanidinium thiocyanate-phenol-chloroform extraction. Annu Rev Biochem. 1987;162:156–159
  28. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press; 1989;
  29. Begley CG, Visvader J, Green AR, et al. Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL. Proc Natl Acad Sci U S A. 1991;1:869–873
  30. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984;311:433–438
  31. Hara T, Miyajima A. Two distinct functional high affinity receptors for mouse interleukin-3 IL-3). EMBO J. 1992;11:1875–1884
  32. Saris CJ, Domen J, Berns A. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J. 1991;10:655–664
  33. Gonda TJ, Metcalf D. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature. 1984;310:249–251
  34. Nicolis S, Bertini C, Ronchi A, et al. An erythroid specific enhancer upstream to the gene encoding the cell-type specific transcription factor GATA-1. Nucleic Acid Res. 1991;19:5285–5291
  35. Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;15:221–226
  36. George KM, Leonard MW, Roth ME, et al. Embryonic expression and cloning of the murine GATA-3 gene. Development. 1994;120:2673–2686
  37. Ramsay RG, Ikeda K, Rifkind RA, Marks PA. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. Proc Natl Acad Sci U S A. 1986;83:6849–6853
  38. Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol. 1993;13:2776–2786
  39. Arcari P, Martinelli R, Salvatore F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acid Res. 1984;11:9179–9189
  40. Beru N, Maples PB, Hermine O, Goldwasser E. Differential expression of alpha- and beta-globin genes in erythroleukemic cell lines. Mol Cell Biol. 1990;10:3591–3595
  41. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF. Ineffective erythropoiesis in Stat5a−/−)5b−/−) mice due to decreased survival of early erythroblasts. Blood. 2001;98:3261–3273
  42. Kreider BL, Benezra R, Rovera G, Kadesch T. Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science. 1992;255:1700–1702
  43. Springhorn JP, Singh K, Kelly RA, Smith TW. Post-transcriptional regulation of Id1 activity in cardiac muscle. Alternative splicing of novel Id1 transcript permits homodimerization. J Biol Chem. 1994;269:5132–5136
  44. Shimada Y, Migliaccio G, Ralph H, Migliaccio AR. Erythropoietin-specific cell cycle progression in erythroid subclones of the IL-3-dependent cell line 32D. Blood. 1993;81:935–941
  45. Miura O, Miura Y, Nakamura N, et al. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood. 1994;84:4135–4141
  46. Mikkers H, Nawijn M, Allen J, et al. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol. 2004;24:6104–6115
  47. Ting CN, Olson MC, Barton KP, Leiden JM. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 1996;384:474–478
  48. Zhao W, Kitidis C, Fleming MD, Lodish HF, Ghaffari S. Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway. Blood. 2006;1:907–915
  49. Kadri Z, Maouche-Chretien L, Rooke HM, et al. Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation. Mol Cell Biol. 2005;25:7412–7422
  50. Tilbrook PA, Palmer GA, Bittorf T, et al. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn. Cancer Res. 2001;15:2453–2458
  51. Okada Y, Nagai R, Sato T, et al. Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 gene. Blood. 2003;15:4748–4756
  52. Hernandez-Hernandez A, Ray P, Litos G, et al. Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1. EMBO J. 2006;25:3264–3274
  53. Hu M, Krause D, Greaves M, et al. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 1997;11:774–785
  54. Drissen R, von Lindern M, Kolbus A, et al. The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability. Mol Cell Biol. 2005;25:5205–5214
  55. Rooke HM, Orkin SH. Phosphorylation of Gata1 at serine residues 72, 142, and 310 is not essential for hematopoiesis in vivo. Blood. 2006;107:3527–3530
  56. Ghinassi B, Sanchez M, Martelli F, et al. The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood. 2006;October 12, prepublished on-line
  57. Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodelling. Proc Natl Acad Sci U S A. 2003;100:8811–8816

PII: S0301-472X(07)00113-0

doi: 10.1016/j.exphem.2007.02.007

Experimental Hematology
Volume 35, Issue 5 , Pages 735-747 , May 2007

Article Tools

* Image Usage & Resolution